Clinical use of rifampicin during routine reporting of rifampicin susceptibilities : a lesson in selective reporting of antimicrobial susceptibility data
Increased use of rifampicin for in-patients was noted after the laboratory began reporting rifampicin susceptibilities routinely for all Gram-positive bacterial isolates. The appropriateness of rifampicin use was evaluated by chart review for in-patients administered rifampicin during two time perio...
Gespeichert in:
Veröffentlicht in: | Journal of antimicrobial chemotherapy 1997-10, Vol.40 (4), p.595-598 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!